CA2077712A1 - Process and device for the production of a contrast medium from a concentrate - Google Patents
Process and device for the production of a contrast medium from a concentrateInfo
- Publication number
- CA2077712A1 CA2077712A1 CA002077712A CA2077712A CA2077712A1 CA 2077712 A1 CA2077712 A1 CA 2077712A1 CA 002077712 A CA002077712 A CA 002077712A CA 2077712 A CA2077712 A CA 2077712A CA 2077712 A1 CA2077712 A1 CA 2077712A1
- Authority
- CA
- Canada
- Prior art keywords
- contrast medium
- production
- concentrate
- liters
- liter
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/0002—General or multifunctional contrast agents, e.g. chelated agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/04—X-ray contrast preparations
- A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
- A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
- A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
- A61K49/1818—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
- A61M31/005—Devices for introducing or retaining media, e.g. remedies, in cavities of the body for contrast media
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/168—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body
- A61M5/16804—Flow controllers
- A61M5/16827—Flow controllers controlling delivery of multiple fluids, e.g. sequencing, mixing or via separate flow-paths
Abstract
Process for the production of a contrast medium from a contrast medium concentrate in an amount of 350-450 I/ml or 0.5-4 mol of contrast medium compound/liter in a container of 0.1-100 liters by mixing with an aqueous solution.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US68892291A | 1991-04-22 | 1991-04-22 | |
EP92250170.5 | 1992-06-29 |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2077712A1 true CA2077712A1 (en) | 1993-12-30 |
CA2077712C CA2077712C (en) | 2003-06-17 |
Family
ID=24766346
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002077712A Expired - Fee Related CA2077712C (en) | 1991-04-22 | 1992-09-08 | Process and device for the production of a contrast medium from a concentrate |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP0576740B1 (en) |
JP (1) | JPH069435A (en) |
AT (1) | ATE168888T1 (en) |
CA (1) | CA2077712C (en) |
DE (1) | DE4121568C2 (en) |
DK (1) | DK0576740T3 (en) |
ES (1) | ES2121816T3 (en) |
Cited By (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9238099B2 (en) | 2004-11-24 | 2016-01-19 | Bayer Healthcare Llc | System and apparatus for modeling pressures generated during an injection procedure |
US9302044B2 (en) | 2006-12-29 | 2016-04-05 | Bayer Healthcare Llc | Patient-based parameter generation systems for medical injection procedures |
US9421330B2 (en) | 2008-11-03 | 2016-08-23 | Bayer Healthcare Llc | Mitigation of contrast-induced nephropathy |
US9616166B2 (en) | 2004-11-16 | 2017-04-11 | Bayer Healthcare Llc | Systems and methods of determining injection protocols for diagnostic imaging procedures |
US9949704B2 (en) | 2012-05-14 | 2018-04-24 | Bayer Healthcare Llc | Systems and methods for determination of pharmaceutical fluid injection protocols based on x-ray tube voltage |
US9959389B2 (en) | 2010-06-24 | 2018-05-01 | Bayer Healthcare Llc | Modeling of pharmaceutical propagation and parameter generation for injection protocols |
US10898638B2 (en) | 2016-03-03 | 2021-01-26 | Bayer Healthcare Llc | System and method for improved fluid delivery in multi-fluid injector systems |
US11141535B2 (en) | 2017-08-31 | 2021-10-12 | Bayer Healthcare Llc | Fluid path impedance assessment for improving fluid delivery performance |
US11278853B2 (en) | 2013-03-13 | 2022-03-22 | Bayer Healthcare Llc | Method for controlling fluid accuracy and backflow compensation |
US11478581B2 (en) | 2017-08-31 | 2022-10-25 | Bayer Healthcare Llc | Fluid injector system volume compensation system and method |
US11598664B2 (en) | 2017-08-31 | 2023-03-07 | Bayer Healthcare Llc | Injector pressure calibration system and method |
US11779702B2 (en) | 2017-08-31 | 2023-10-10 | Bayer Healthcare Llc | Method for dynamic pressure control in a fluid injector system |
US11786652B2 (en) | 2017-08-31 | 2023-10-17 | Bayer Healthcare Llc | System and method for drive member position and fluid injector system mechanical calibration |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE69432582T2 (en) * | 1993-10-28 | 2003-11-27 | Medrad Inc | System for the administration of liquids in several patients |
US5569181A (en) * | 1993-10-28 | 1996-10-29 | Medrad, Inc. | Sterility assurance for contrast delivery system |
US5827219A (en) * | 1993-10-28 | 1998-10-27 | Medrad, Inc. | Injection system and pumping system for use therein |
EP1258262A3 (en) * | 1993-10-28 | 2002-12-18 | Medrad, Inc. | Total system for contrast delivery |
DE69526613T2 (en) * | 1994-07-12 | 2002-08-29 | Medrad Inc | Information path control loop for a system that delivers medical fluids |
US5840026A (en) * | 1994-09-21 | 1998-11-24 | Medrad, Inc. | Patient specific dosing contrast delivery systems and methods |
DE19648650C2 (en) * | 1996-01-29 | 1998-07-02 | Schering Ag | Buffer systems and their use to stabilize pharmaceutical preparations |
US7267667B2 (en) * | 2002-07-11 | 2007-09-11 | Boston Scientific Scimed, Inc. | Fluid management system for coronary intervention |
JP4620929B2 (en) | 2002-09-26 | 2011-01-26 | 株式会社根本杏林堂 | Chemical injection device |
DE602005005049T2 (en) * | 2004-05-27 | 2009-03-12 | E-Z-Em, Inc. | SYSTEM, METHOD AND COMPUTER PROGRAM PRODUCT FOR HANDLING, MIXTURE, ISSUE AND INJECTION RADIOPHARMACEUTIC AGENT |
EP2170165B1 (en) | 2007-07-17 | 2018-12-05 | Bayer Healthcare LLC | Systems for determination of parameters for a procedure, for estimation of cardiopulmonary function and for fluid delivery |
ITFI20080186A1 (en) * | 2008-09-30 | 2010-04-01 | Maspres Di Alfredo Speranzi | MSA MIXER 206 |
WO2013043889A1 (en) | 2011-09-21 | 2013-03-28 | Medrad, Inc. | System and assembly method for a fluid pump device for a continuous multi-fluid delivery system |
DE102014017402A1 (en) | 2014-11-25 | 2016-05-25 | Fidica Gmbh & Co. Kg | Arrangement for storing and administering rinsing solutions |
DE102014017420A1 (en) | 2014-11-25 | 2016-05-25 | Fidica Gmbh & Co. Kg | Concentrate for rinsing solutions |
DE102014017403A1 (en) | 2014-11-25 | 2016-05-25 | Fidica Gmbh & Co. Kg | RO plant for rinsing solutions |
DE102014017397B4 (en) | 2014-11-25 | 2018-06-21 | Fidica Gmbh & Co. Kg | Mobile flush solution tank |
DE102014017404A1 (en) | 2014-11-25 | 2016-05-25 | Fidica Gmbh & Co. Kg | Monitoring RO system for rinsing solutions |
DE102014017399A1 (en) | 2014-11-25 | 2016-05-25 | Fidica Gmbh & Co. Kg | Mixing plant for ready-to-use rinse solutions |
AU2016205275B2 (en) | 2015-01-09 | 2020-11-12 | Bayer Healthcare Llc | Multiple fluid delivery system with multi-use disposable set and features thereof |
JP6516584B2 (en) * | 2015-06-22 | 2019-05-22 | 大陽日酸株式会社 | Contrast agent supply device |
GB201703227D0 (en) * | 2017-01-20 | 2017-04-12 | Ge Healthcare As | Plastic containers |
GB201721463D0 (en) * | 2017-12-20 | 2018-01-31 | Ge Healthcare As | Tailored dose of contrast agent |
CN109984772A (en) * | 2019-05-20 | 2019-07-09 | 广东省人民医院(广东省医学科学院) | A kind of left cardiography check device |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4467844A (en) * | 1982-06-24 | 1984-08-28 | Baxter Travenol Laboratories, Inc. | Flow monitoring method and apparatus |
DE3315031C2 (en) * | 1983-04-26 | 1985-09-05 | Pfrimmer-Viggo GmbH & Co KG, 8520 Erlangen | Method and device for producing mixtures of pharmaceutical liquids |
-
1991
- 1991-06-29 DE DE4121568A patent/DE4121568C2/en not_active Expired - Fee Related
-
1992
- 1992-06-29 ES ES92250170T patent/ES2121816T3/en not_active Expired - Lifetime
- 1992-06-29 EP EP92250170A patent/EP0576740B1/en not_active Expired - Lifetime
- 1992-06-29 DK DK92250170T patent/DK0576740T3/en active
- 1992-06-29 AT AT92250170T patent/ATE168888T1/en not_active IP Right Cessation
- 1992-09-07 JP JP4237869A patent/JPH069435A/en active Pending
- 1992-09-08 CA CA002077712A patent/CA2077712C/en not_active Expired - Fee Related
Cited By (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9616166B2 (en) | 2004-11-16 | 2017-04-11 | Bayer Healthcare Llc | Systems and methods of determining injection protocols for diagnostic imaging procedures |
US9950107B2 (en) | 2004-11-24 | 2018-04-24 | Bayer Healthcare Llc | Systems and methods for managing workflow for injection procedures |
US9238099B2 (en) | 2004-11-24 | 2016-01-19 | Bayer Healthcare Llc | System and apparatus for modeling pressures generated during an injection procedure |
US10166326B2 (en) | 2004-11-24 | 2019-01-01 | Bayer Healthcare Llc | Devices, systems and methods for determining parameters of one or more phases of an injection procedure |
US10463782B2 (en) | 2006-12-29 | 2019-11-05 | Bayer Healthcare Llc | Patient-based parameter generation systems for medical injection procedures |
US9302044B2 (en) | 2006-12-29 | 2016-04-05 | Bayer Healthcare Llc | Patient-based parameter generation systems for medical injection procedures |
US9421330B2 (en) | 2008-11-03 | 2016-08-23 | Bayer Healthcare Llc | Mitigation of contrast-induced nephropathy |
US9959389B2 (en) | 2010-06-24 | 2018-05-01 | Bayer Healthcare Llc | Modeling of pharmaceutical propagation and parameter generation for injection protocols |
US11191501B2 (en) | 2012-05-14 | 2021-12-07 | Bayer Healthcare Llc | Systems and methods for determination of pharmaceutical fluid injection protocols based on x-ray tube voltage |
US9949704B2 (en) | 2012-05-14 | 2018-04-24 | Bayer Healthcare Llc | Systems and methods for determination of pharmaceutical fluid injection protocols based on x-ray tube voltage |
US11278853B2 (en) | 2013-03-13 | 2022-03-22 | Bayer Healthcare Llc | Method for controlling fluid accuracy and backflow compensation |
US10898638B2 (en) | 2016-03-03 | 2021-01-26 | Bayer Healthcare Llc | System and method for improved fluid delivery in multi-fluid injector systems |
US11672902B2 (en) | 2016-03-03 | 2023-06-13 | Bayer Healthcare Llc | System and method for improved fluid delivery in multi-fluid injector systems |
US11141535B2 (en) | 2017-08-31 | 2021-10-12 | Bayer Healthcare Llc | Fluid path impedance assessment for improving fluid delivery performance |
US11478581B2 (en) | 2017-08-31 | 2022-10-25 | Bayer Healthcare Llc | Fluid injector system volume compensation system and method |
US11598664B2 (en) | 2017-08-31 | 2023-03-07 | Bayer Healthcare Llc | Injector pressure calibration system and method |
US11779702B2 (en) | 2017-08-31 | 2023-10-10 | Bayer Healthcare Llc | Method for dynamic pressure control in a fluid injector system |
US11786652B2 (en) | 2017-08-31 | 2023-10-17 | Bayer Healthcare Llc | System and method for drive member position and fluid injector system mechanical calibration |
US11826553B2 (en) | 2017-08-31 | 2023-11-28 | Bayer Healthcare Llc | Fluid path impedance assessment for improving fluid delivery performance |
Also Published As
Publication number | Publication date |
---|---|
DE4121568A1 (en) | 1992-10-29 |
EP0576740B1 (en) | 1998-07-29 |
ATE168888T1 (en) | 1998-08-15 |
ES2121816T3 (en) | 1998-12-16 |
DE4121568C2 (en) | 1997-07-03 |
CA2077712C (en) | 2003-06-17 |
EP0576740A1 (en) | 1994-01-05 |
DK0576740T3 (en) | 1999-04-26 |
JPH069435A (en) | 1994-01-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2077712A1 (en) | Process and device for the production of a contrast medium from a concentrate | |
AU3107093A (en) | Synthesis of creping aids based on polyamides containing methyl bis(3-aminopropylamine) | |
KR0135639B1 (en) | Ink used for high-image quality recording system | |
CA2140923A1 (en) | Lowering the pH of Textile Processing Solution with an Acid/Base Salt as a pH Adjusting Agent | |
HK1004254A1 (en) | Rack for condiment dispensers | |
CA2158343A1 (en) | Bottle for containing a fluid | |
CA2136492A1 (en) | Pharmaceutical composition containing diclofenac and 2-hydroxypropyl-.beta.-cyclodextrin | |
CA2036283A1 (en) | Effervescent composition, its production and use | |
EP0590271A3 (en) | 17-aryl and 17-heterocyclyl-14beta-5alpha-androstane, androstene and androstadiene derivatives active on the cardiovascular system, processes for their preparation and pharmaceutical compositions containing same | |
CA2069171A1 (en) | Stabilization of aqueous polymers in the presence of hydroxylamine | |
AP9600810A0 (en) | Crystalline n-acetyl neuraminic acid derivatives and processes for their preparation. | |
CA2153663A1 (en) | Separation of nylon 6 from mixtures with nylon 6,6 | |
PL308203A1 (en) | Synthesis of n-acetloneuraminic acid derivatives | |
AU5629694A (en) | Cryoprotective aqueous solutions useful for the preservation of (in vitro) cultured epithelial sheets | |
CA2023114A1 (en) | Microorganism for selective production of a specific component of avermectin and a method for selective production thereof | |
CA2052640A1 (en) | Method for destroying cyst of noxious plankton | |
TW276983B (en) | ||
TW243446B (en) | ||
AU5065190A (en) | A non-acidified milk-based drink with a ph value of between 3.6 and 4.2, together with the production process for such a drink | |
CA2112407A1 (en) | Fiber beverage and method of manufacture | |
AU2947084A (en) | Bicyclo (3.2.1) octane carboxylic acid derivatives | |
EP0636604A3 (en) | Process for the preparation of substantially salt-free aqueous Bis-aminooxy-alkane solutions. | |
JPS6486862A (en) | Instant carbonated beverage | |
AU8174894A (en) | Nourishing composition for animals | |
HU9601582D0 (en) | Microbial process for the preparation of heteroaromatic carbonic acids by microorganisms of the genus alcaligenes |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
MKLA | Lapsed |